Marketing-authorisation holder · United States
Igi Labs Inc
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NALBUPHINE HYDROCHLORIDE100mg/10ml (10mg/ml) | 10mg/ml (10mg/ml) | 200mg/10ml (20mg/ml) | 20mg/ml (20mg/ml) · Solution | Nalbufine | United States | Marketed | 1986 |
| PANCURONIUM BROMIDE1mg/ml | 2mg/ml · Injectable | Pancuronium | United States | Marketed | 1988 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- igi labs
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
U.S. Food and Drug Administration (Drugs@FDA, openFDA)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Headquarters
- United States
- Medicines
- 2
- Countries
- 1
- Roles
- Authorisation holder